Skip to main content

Table 4 Adverse effects

From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Side Effects

No of Patients

Side Effects

No of Patients

Wt Gain

6

Pigmentation

4

Rashes

6

Hepatotoxicity

9

Swelling

9

Myelosuppresion

31

Nausea

5

Gum bleeding

3

Vomiting

5

Mild arthralgia

2

Diarrhea

5

Others

9